Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 67

1.

Association of Matrix Metalloproteinase-9 rs3918242 Promoter Genotypes With Colorectal Cancer Risk.

Wu MH, Tzeng HE, Wu CN, Yueh TC, Peng YC, Tsai CH, Wang YC, Ke TW, Pei JS, Chang WS, Tsai CW, Bau DT.

Anticancer Res. 2019 Dec;39(12):6523-6529. doi: 10.21873/anticanres.13867.

PMID:
31810917
2.

Sorafenib treatment on Chinese patients with advanced hepatocellular carcinoma: A study on prognostic factors of the viral and tumor status.

Lee SW, Lee TY, Peng YC, Yang SS, Yeh HZ, Chang CS.

Medicine (Baltimore). 2019 Nov;98(44):e17692. doi: 10.1097/MD.0000000000017692.

3.

Association of virological breakthrough and clinical outcomes in entecavir-treated HBeAg-positive chronic hepatitis B.

Huang YJ, Yang SS, Yeh HZ, Chang CS, Peng YC.

PLoS One. 2019 Aug 30;14(8):e0221958. doi: 10.1371/journal.pone.0221958. eCollection 2019.

4.

Specific adverse events predict survival rates in a Chinese population diagnosed with hepatocellular carcinoma and treated with sorafenib.

Lee SW, Lee TY, Yang SS, Peng YC, Yeh HZ, Chang CS.

JGH Open. 2018 Oct 15;3(1):10-16. doi: 10.1002/jgh3.12096. eCollection 2019 Feb.

5.

Ectopic papilla of Vater in duodenum bulb: A hospital-based study.

Peng YC, Chow WK.

Medicine (Baltimore). 2019 Feb;98(8):e14642. doi: 10.1097/MD.0000000000014642.

6.

The incidence of esophageal cancer and dysplasia in a Chinese population with nondysplastic Barrett's esophagus.

Lee SW, Lien HC, Peng YC, Lin MX, Ko CW, Chang CS.

JGH Open. 2018 Aug 9;2(5):214-216. doi: 10.1002/jgh3.12075. eCollection 2018 Oct.

7.

Proton Pump Inhibitor Use is Associated With Risk of Pancreatic Cancer: A Nested Case-Control Study.

Peng YC, Lin CL, Hsu WY, Lu IT, Yeh HZ, Chang CS, Kao CH.

Dose Response. 2018 Oct 1;16(4):1559325818803283. doi: 10.1177/1559325818803283. eCollection 2018 Oct-Dec.

8.

Association Between Cholangiocarcinoma and Proton Pump Inhibitors Use: A Nested Case-Control Study.

Peng YC, Lin CL, Hsu WY, Chow WK, Lee SW, Yeh HZ, Chen CC, Kao CH.

Front Pharmacol. 2018 Jul 3;9:718. doi: 10.3389/fphar.2018.00718. eCollection 2018.

9.

The association between bowel obstruction and the management of cholelithiasis and cholecystitis in elderly patients: A population-based cohort study.

Peng YC, Lin CL, Yeh HZ, Chang CS, Kao CH.

Eur J Intern Med. 2018 Nov;57:83-90. doi: 10.1016/j.ejim.2018.07.005. Epub 2018 Jul 9.

PMID:
30001868
10.

Regulation of the regulator of G protein signaling 2 expression and cellular localization by PKA and PKC pathways in mouse granulosa cells.

Yeh HY, Sun D, Peng YC, Wu YL.

Biochem Biophys Res Commun. 2018 Sep 5;503(2):950-955. doi: 10.1016/j.bbrc.2018.06.101. Epub 2018 Jun 21.

PMID:
29932914
11.

Prevalence of Hepatitis B Reactivation Among Chinese Individuals With Chronic Hepatitis C Treated With Pan-Oral Direct-Acting Antivirals.

Lee SW, Lee TY, Yang SS, Peng YC, Yeh HZ, Chang CS.

Gastroenterology Res. 2018 Apr;11(2):124-129. doi: 10.14740/gr971w. Epub 2018 Apr 7.

12.

Risk of pyogenic liver abscess and endoscopic sphincterotomy: a population-based cohort study.

Peng YC, Lin CL, Sung FC.

BMJ Open. 2018 Mar 3;8(3):e018818. doi: 10.1136/bmjopen-2017-018818.

13.

Association between proton pump inhibitors use and risk of gastric cancer in patients with GERD.

Peng YC, Huang LR, Lin CL, Hsu WY, Chang CS, Yeh HZ, Kao CH.

Gut. 2019 Feb;68(2):374-376. doi: 10.1136/gutjnl-2018-316057. Epub 2018 Feb 22. No abstract available.

PMID:
29472295
14.

Relationship between use of selective serotonin reuptake inhibitors and irritable bowel syndrome: A population-based cohort study.

Lin WT, Liao YJ, Peng YC, Chang CH, Lin CH, Yeh HZ, Chang CS.

World J Gastroenterol. 2017 May 21;23(19):3513-3521. doi: 10.3748/wjg.v23.i19.3513.

15.

The association between cholecystectomy and colorectal neoplasm in inflammatory bowel diseases: A population-based cohort study.

Peng YC, Lin CL, Sung FC.

PLoS One. 2017 May 26;12(5):e0177745. doi: 10.1371/journal.pone.0177745. eCollection 2017.

16.

The Diagnostic Value of Alarm Features for Identifying Types and Stages of Upper Gastrointestinal Malignancies.

Lee SW, Chang CS, Yeh HJ, Lien HC, Lee TY, Peng YC.

Gastroenterology Res. 2017 Apr;10(2):120-125. doi: 10.14740/gr826w. Epub 2017 Apr 19.

17.

Correlation Between Symptom Severity and Health-Related Life Quality of a Population With Gastroesophageal Reflux Disease.

Lee SW, Lee TY, Lien HC, Peng YC, Yeh HJ, Chang CS.

Gastroenterology Res. 2017 Apr;10(2):78-83. doi: 10.14740/gr753w. Epub 2017 Apr 19.

18.

The effect of proton pump inhibitors on the gastric mucosal microenvironment.

Peng YC, Huang LR, Ho HC, Chang CS, Lee SW, Cheng CC, Wen MC, Yeh HZ, Ho SP.

Adv Clin Exp Med. 2017 Jan-Feb;26(1):39-43. doi: 10.17219/acem/33116.

19.

The association of non-alcoholic fatty liver disease and metabolic syndrome in a Chinese population.

Lee SW, Lee TY, Yang SS, Peng YC, Yeh HZ, Chang CS.

Hepatobiliary Pancreat Dis Int. 2017 Apr;16(2):176-180.

PMID:
28381382
20.

On-treatment HBV DNA dynamics predict virological breakthrough in entecavir-treated HBeAg-positive chronic hepatitis B.

Huang YJ, Chang CS, Peng YC, Yeh HZ, Yang SS.

PLoS One. 2017 Mar 28;12(3):e0174046. doi: 10.1371/journal.pone.0174046. eCollection 2017.

Supplemental Content

Loading ...
Support Center